The recipient CCR5 variation predicts survival outcomes after bone marrow transplantation-Reference-Cited by-同舟云学术

The recipient CCR5 variation predicts survival outcomes after bone marrow transplantation

Published:2017-06 Issue: Volume:42 Page:34-39
ISSN:0966-3274
Container-title:Transplant Immunology
language:en
Short-container-title:Transplant Immunology

Author:

Horio Tomohiro^ORCID,Mizuno Shohei,Uchino Kaori,Mizutani Motonori,Hanamura Ichiro,Espinoza J. Luis,Onizuka Makoto,Kashiwase Koichi,Morishima Yasuo,Fukuda Takahiro,Kodera Yoshihisa,Doki Noriko,Miyamura Koichi,Mori Takehiko,Takami Akiyoshi

Publisher

Elsevier BV

Subject

Transplantation,Immunology,Immunology and Allergy

Reference28 articles.

1. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia;Mengarelli;Haematologica,2002

2. Allogeneic transplantation for AML and MDS: GVL versus GVHD and disease recurrence;van Besien;Hematology Am. Soc. Hematol. Educ. Program,2013

3. Chemokines: a new classification system and their role in immunity;Zlotnik;Immunity,2000

4. Therapy for, polymorphism of CCR5 affecting HIV disease progression in the Japanese population;Kageyama;AIDS Res. Hum. Retrovir.,2001

5. Incidence and dynamics of active cytomegalovirus infection in allogeneic stem cell transplant patients according to single nucleotide polymorphisms in donor and recipient CCR5, MCP-1, IL-10, and TLR9 genes;Corrales;J. Med. Virol.,2015

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. C–C chemokine receptor 5 and acute graft‐versus‐host disease;Immunity, Inflammation and Disease;2022-08-17

2. Overview of Research on Germline Genetic Variation in Immune Genes and Cancer Outcomes;Cancer Epidemiology, Biomarkers & Prevention;2022-03-01

3. Donor UNC-93 Homolog B1 genetic polymorphism predicts survival outcomes after unrelated bone marrow transplantation;Genes & Immunity;2021-02-24

4. Donor Heme Oxygenase-1 Promoter Gene Polymorphism Predicts Survival after Unrelated Bone Marrow Transplantation for High-Risk Patients;Cancers;2020-02-12

5. The Expanding Therapeutic Perspective of CCR5 Blockade;Frontiers in Immunology;2018-01-12